South Korea
Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark
Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu Assay result of Seegene's decades-long know-how, applies D...
April 07, 2022 | News
BIO KOREA, Asia's Biggest Bio-Health Convention, to Open in May 2022
Initiated in 2006, BIO KOREA is the biggest bio-health convention in Asia that is dedicated to promoting the international standing of Korea's he...
April 07, 2022 | News
Samsung Biologics holds 11th Annual General Meeting of Shareholders
Five matters were presented and approved unanimously at this year's meeting, which included the approval of financial statement, appointment of directors, ...
March 29, 2022 | News
RNAGENE Signs a Collaborative Research Agreement with PharmAbcine to Develop Novel mRNA Therapeutics
Under the agreement, both companies will collaborate to develop next-generation mRNA-based antibody therapeutics by utilizing the proprietary mRNA platform...
March 22, 2022 | News
KHIDI Presenting the latest healthcare technologies with leading innovation companies of South Korea
Korea Health Industry Development Institute (KHIDI) announced its operation of the Korean pavilion at the 2022 HIMSS Global Health Conference & Ex...
March 16, 2022 | News
Everest Medicines to further enhance its international commercial footprint
Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical u...
March 14, 2022 | News
PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial
The clinical study, which had the first patient dosed in December 2018, evaluated the safety and clinical efficacy of olinvacimab, the Company's anti-...
February 28, 2022 | News
Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era
Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today, announced the CE-IVD marking of its Allplex™ SARS-CoV...
February 25, 2022 | News
RosVivo signed MTA for diabetes treatment with Eli Lilly and Company
RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest ...
February 23, 2022 | News
Samsung Biologics receives 2022 CMO Leadership Award in all six categories
Now in its 11th year, the CMO Leadership Awards offer accurate and reliable customer feedback to provide support in choosing a reputable partner for develo...
February 08, 2022 | News
LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology
Scripps Research is the top nonprofit scientific institute in the US for producing high-quality research based on discoveries published in leading scientif...
February 04, 2022 | News
iMediSync Successfully Launches the Future of Tele-Medicare at CES 2022
iMediSync, A biotech startup company from Seoul, South Korea, successfully debuted at CES 2022 to introduce the new trend of digital healthc...
January 28, 2022 | News
Biogen to acquire full ownership of Samsung Bioepis
Agreement with Biogen to buyout Biogen's (50% -1 share) stake in Samsung Bioepis Joint Venture for up to USD $2.3 billion Transaction projected to ...
January 28, 2022 | News
Daewoong Pharmaceutical Released Positive Phase 3 Topline Results for New Antidiabetic Drug
Daewoong Pharmaceutical (Daewoong) has confirmed promising phase 3 topline results that focuses on the therapeutic effects as an Enavogliflozin monotherapy...
January 26, 2022 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
